椎體成形術和後凸成形術市場的增長，趨勢和預測（2020-2025）

Vertebroplasty and Kyphoplasty Market - Growth, Trends, and Forecast (2020 - 2025)

出版日期: 2020年08月01日 | 出版商:

Mordor Intelligence Pvt Ltd | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全貌
簡介
目錄

簡介

由於產品技術的進步和椎體壓縮性骨折患者的增加，預計在整個預測期內，全球椎骨和整骨市場將以4.5％的複合年增長率增長。脊柱壓縮性骨折是骨質疏鬆症患者中最常見的骨折。

據美國神經外科醫師協會稱，每年約有75,000人經歷過脊柱壓縮性骨折。例如，Merit Medical最近宣佈了兩種用於脊柱壓縮性骨折的產品，Diamond TOUCH和StabiliT。
注射器不僅噴射骨水泥，而且使介入裝置膨脹和收縮。因此，預計這些因素將推動椎骨和椎體成形術市場的需求。
然而，與椎骨和椎體整形相關的產品的監管規定有望阻礙市場增長。

該報告調查了椎骨和椎體成形術市場，分析了市場概況，市場增長和障礙，市場規模趨勢以及按類型和地區，競爭狀況，主要情況做出的預測它提供全面的信息，例如公司簡介和市場機會。

The vertebroplasty and kyphoplasty market is expected to register a CAGR of 4.5% over the forecast period, owing to technological advancements in product and increasing burden of vertebral compression fracture. Vertebral compression fractures are the most prevalent fractures in osteoporosis patients.

According to the American Association of Neurological Surgeons, around 75,000 people experience vertebral compression fractures every year. For instance, recently Merit Medical introduced two products for vertebral compression fracture, 'DiamondTOUCH' and 'StabiliT'.
The syringe has the capability of injecting cement as well as to inflate and deflate the interventional devices. Hence, these factors are expected to boost the demand for vertebroplasty and kyphoplasty market.
However, the clearance of the products related to vertebroplasty and kyphoplasty by regulatory bodies is expected to obstruct the market growth.

Key Market Trends

Kyphoplasty Devices are Expected to Exhibit a Significant Share in the Vertebroplasty and Kyphoplasty Market

Kyphoplasty devices are expected to exhibit significant growth, owing to the changing lifestyle of people. The adaptation of a sedentary lifestyle by the people has led to physical inactivity, which involves high complications and risk. Even in the patients of osteoporosis and osteopenia, physical exercise reduces the risk of vertebral fractures.

Furthermore, the growing prevalence of vertebral compression fracture, and according to the study of Osteoporosis International, in 2017, around 30% - 50% of people worldwide had been affected with a vertebral compression fracture. Also, according to the study of the Journal of Spine Surgery published in 2019, the kyphoplasty that was performed for vertebral height restoration showed significant outcomes. Therefore, these factors are expected to propel the growth of the vertebroplasty and kyphoplasty market in this segment.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the global vertebroplasty and kyphoplasty market, owing to the increasing aging population and the presence of product approvals. A vertebral compression fracture is commonly found in the geriatric population. According to the American Association of Neurological Surgeon, a vertebral compression fracture is quite common in older women than men. It affects almost 40% of the women aged 80 and above in the United States. Cardinal Health recently received a US FDA (Food & Drug Administration) approval for its product, 'Ava-Tex Radiopaque Bone Cement', which may be used in the spine fracture surgeries, i.e., vertebroplasty. Such activities may boost the growth of demand and usage for these procedures in the market studied.

Competitive Landscape

The vertebroplasty and kyphoplasty market is fragmented and consists of several major players. In terms of market share, few of the major players have been currently dominating the market. Companies have been taking strategic initiatives to grow their presence in the market studied. For instance, in 2019, Medtronic acquired Titan Spine to expand its product portfolio related to spinal surgery. Some of the companies that are currently dominating the market are Medtronic, Medaid Inc., Teknimed, Cardinal Health, Johnson & Johnson (Depuy Synthes), joimax GmbH, Stryker, Atcomed, Lindare Medical, and Globus Medical.

Reasons to Purchase this report:

The market estimate (ME) sheet in Excel format
3 months of analyst support

1 INTRODUCTION

1.1 Study Assumptions
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview
4.2 Market Drivers
- 4.2.1 Rising Geriatric Population
- 4.2.2 Technological Advancements in the Products
4.3 Market Restraints
- 4.3.1 Stringent Regulatory Framework
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

5.1 By Product Type
- 5.1.1 Vertebroplasty Devices
- 5.1.2 Kyphoplasty Devices
5.2 Geography
- 5.2.1 North America
  - 5.2.1.1 United States
  - 5.2.1.2 Canada
  - 5.2.1.3 Mexico
- 5.2.2 Europe
  - 5.2.2.1 Germany
  - 5.2.2.2 United Kingdom
  - 5.2.2.3 France
  - 5.2.2.4 Italy
  - 5.2.2.5 Spain
  - 5.2.2.6 Rest of Europe
- 5.2.3 Asia-Pacific
  - 5.2.3.1 China
  - 5.2.3.2 Japan
  - 5.2.3.3 India
  - 5.2.3.4 Australia
  - 5.2.3.5 South Korea
  - 5.2.3.6 Rest of Asia-Pacific
- 5.2.4 Middle East & Africa
  - 5.2.4.1 GCC
  - 5.2.4.2 South Africa
  - 5.2.4.3 Rest of Middle East & Africa
- 5.2.5 South America
  - 5.2.5.1 Brazil
  - 5.2.5.2 Argentina
  - 5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles
- 6.1.1 Medtronic
- 6.1.2 Medaid Inc.
- 6.1.3 Teknimed
- 6.1.4 Cardinal health
- 6.1.5 Johnson & Johnson (Depuy Synthes)
- 6.1.6 Joimax GmbH
- 6.1.7 Stryker
- 6.1.8 Atcomed
- 6.1.9 Lindare Medical
- 6.1.10 Globus Medical